Insiders · Profile

ADAMS R MARK

Chief Operating Officer at Adaptive Biotechnologies. Filing since 7 Apr 2021. CIK 0001808905

Company
Date
Role
Action
Shares
Amount
Of holding
11 Apr 2023
Chief Operating Officer
Sold on a plan
2,308
$19.92K
1.3%
10 Apr 2023
Chief Operating Officer
Sold on a plan
817
$6.94K
0.5%
7 Mar 2023
Chief Operating Officer
Sold, plan not stated
17,155
$147.53K
8.8%
6 Mar 2023
Chief Operating Officer
Sold, plan not stated
6,529
$55.95K
3.2%
10 Jan 2023
Chief Operating Officer
Sold, plan not stated
2,130
$18.28K
1.8%
9 Jan 2023
Chief Operating Officer
Sold, plan not stated
995
$8.46K
0.9%
10 Oct 2022
Chief Operating Officer
Sold, plan not stated
2,284
$16.28K
1.9%
7 Oct 2022
Chief Operating Officer
Sold, plan not stated
841
$6.40K
0.7%
8 Jul 2022
Chief Operating Officer
Sold, plan not stated
2,300
$24.08K
1.9%
7 Jul 2022
Chief Operating Officer
Sold, plan not stated
825
$7.86K
0.7%
7 Apr 2022
Chief Operating Officer
Sold, plan not stated
831
$10.94K
0.7%
7 Mar 2022
Chief Operating Officer
Sold, plan not stated
1,244
$14.94K
1.0%
7 Jan 2022
Chief Operating Officer
Sold, plan not stated
1,021
$23.81K
2.0%
8 Oct 2021
Chief Operating Officer
Sold, plan not stated
1,801
$60.64K
3.4%
7 Oct 2021
Chief Operating Officer
Sold, plan not stated
1,324
$42.99K
2.4%
8 Jul 2021
Chief Operating Officer
Sold, plan not stated
2,254
$81.82K
3.9%
7 Jul 2021
Chief Operating Officer
Sold, plan not stated
871
$34.33K
1.5%
17 Jun 2021
Chief Operating Officer
Sold, plan not stated
14,583
$583.32K
20.1%
14 Jun 2021
Chief Operating Officer
Sold, plan not stated
8,914
$345.60K
13.3%
7 Apr 2021
Chief Operating Officer
Sold, plan not stated
3,586
$151.83K
5.1%
20 decisions on file.